Literatur
Boyce JM (2001) MRSA patients: proven methods to treat colonization and infection. J Hosp Infect 48 Suppl A: S9–14
Bronzwaer SL, Buchholz U, Kool JL, Monen J, Schrijnemakers P (2001) EARSS activities and results: update. Euro Surveill 6: 2–5
Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C (1999) Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 282: 1745–1751
Empfehlung zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus (MRSA)-Stämmen in Krankenhäusern und anderen medizinischen Einrichtungen. (1999) Bundesgesundheitsblatt 42: 958
Francois P, Pittet D, Bento M et al. (2003) Rapid detection of methicillin-resistant staphylococcus aureus directly from sterile or nonsterile clinical samples by a new molecular assay. J Clin Microbiol 41: 254–260
Gastmeier P, Sohr D, Geffers C et al. (2002) Occurrence of methicillin-resistant Staphylococcus aureus infections in German intensive care units. Infection 30: 198–202
Harbarth S, Liassine N, Dharan S et al. (2000) Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 31: 1380–1385
Herrmann M, Peters G (1995) Virulence factors in Staphylococcus aureus. In: Brun-Buisson C, Casewell M, El-Solh N, Regnier B (eds) Flammarion Médecine Sciences, Paris
Hiramatsu K, Aritaka N, Hanaki H et al. (1997) Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350: 1670–1673
Huang SS, Platt R (2003) Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 36: 281–5
Lucet JC, Chevret S, Durand-Zaleski I, Chastang C, Regnier B (2003) Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study. Arch Intern Med 163: 181–188
Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections--Los Angeles County, California, 2002–2003. (2003) MMWR 52: 88
Papia G, Louie M, Tralla A, Johnson C, Collins V, Simor AE (1999) Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective? Infect Control Hosp Epidemiol 20: 473–477
Pittet D, Tarara D, Wenzel RP (1994) Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 271: 1598–1601
Salgado CD, Farr BM, Calfee DP (2003) Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 36: 131–139
Staphylococcus aureus resistant to vancomycin--United States, 2002. (2002) MMWR Morb Mortal Wkly Rep 51: 565–567
von Eiff C, Becker K, Machka K, Stammer H, Peters G (2001) Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 344: 11–6
von Eiff C, Heilmann C, Herrmann M, Peters G (1999) Basic aspects of the pathogenesis of staphylococcal polymer-associated infections. Infection 27 Suppl 1: S7–10
Weinstein MP, Towns ML, Quartey SM et al. (1997) The clinical significance of positive blood cultures in the 1990 s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 24: 584–602
Whitby M, McLaws ML, Berry G (2001) Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust 175: 264–267
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wüllenweber, J., Herrmann, M. Methicillinresistenter Staphylococcus aureus—Klinik und Therapie. HNO 51, 451–455 (2003). https://doi.org/10.1007/s00106-003-0875-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00106-003-0875-1